Ana Alonso Varona
Corporate Officer/Principal at Histocell SL
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Teodoro Palomares | M | - |
Histocell SL
 Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain.
The University of the Basque Country
| - |
| Elia Fernández | F | - |
Histocell SL
Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | 18 years |
| Mario Fernández Pelaz | M | 81 |
The University of the Basque Country
| - |
| Emiliano López Achurra | M | - |
The University of the Basque Country
| - |
| Fernando Pedro Cossío Mora | M | - |
The University of the Basque Country
| - |
| Arantza Mendizábal Gorostiaga | M | 74 |
The University of the Basque Country
| - |
| Roberto Velasco Barroetabeña | M | - |
The University of the Basque Country
| - |
| Julio Font | M | - |
Histocell SL
Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | - |
| Pedro Miguel Etxenike | M | - |
The University of the Basque Country
| - |
| María Eugenia Zugaza Salazar | F | - |
The University of the Basque Country
| - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Spain | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ana Alonso Varona
- Personal Network
